
Intravenous Infusion Pump Market Report and Forecast 2025-2034
Description
The global intravenous infusion pump market size was valued at USD 5.30 Billion in 2024, driven by the rising prevalence of chronic diseases across the globe. The market is expected to grow at a CAGR of 7.60% during the forecast period of 2025-2034, with the values likely to rise from to USD 11.03 Billion by 2034.
Intravenous Infusion Pump: Introduction
An intravenous infusion pump is a device used to administer medication or fluids into a patient's body for treating high blood pressure. They offer significant advantage over manual administration as it capable of delivering fluids at precisely programmed intervals and in smaller volumes as well.
Infusion pumps can be stationary or portable depending on the patient’s requirement. Some pumps are equipped with safety measures like an alarm clock or other operator alerts as well. They may be mechanically or electrically powered.
Global Intravenous Infusion Pump Market Analysis
Intravenous infusion must be highly precise because even minute changes can threaten a patient's life. As a result, authorities like the FDA and EU continuously evaluate the efficacy of prevailing devices. To curb the high intravenous infusion pump market demand, prominent healthcare companies keep on bringing updated versions of devices.
Recently, FDA approved the redistribution of BD’s Alaris infusion pump in the market. This latest version is enabled with new software, hardware, and cybersecurity updates to deliver precise medications to the patients.
In August 2023, ICU Medical received 510(k) FDA clearance to its Plum Duo infusion pump, enabled with LifeShield infusion safety software. This pump features a large touch screen that enables an intuitive user interface as well. Similarly, Baxter’s Novum IQ syringe infusion pump (SYR) is paired with Dose IQ safety software that provides enhanced safety features, connectivity and a vast portfolio of sets designed to deliver optimum dose precision.
With a surge in innovations and digital integration into healthcare and medical devices, IOT (internet of things) controlled devices are set to emerge in the market. Researchers are working on developing remote monitoring enabled infusion pumps for accurate detection of patient’s vitals. Such technologies will enhance the intravenous infusion pump market growth in the upcoming years.
Global Intravenous Infusion Pump Market Segmentation
Intravenous Infusion Pump Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Intravenous Infusion Pump: Introduction
An intravenous infusion pump is a device used to administer medication or fluids into a patient's body for treating high blood pressure. They offer significant advantage over manual administration as it capable of delivering fluids at precisely programmed intervals and in smaller volumes as well.
Infusion pumps can be stationary or portable depending on the patient’s requirement. Some pumps are equipped with safety measures like an alarm clock or other operator alerts as well. They may be mechanically or electrically powered.
Global Intravenous Infusion Pump Market Analysis
Intravenous infusion must be highly precise because even minute changes can threaten a patient's life. As a result, authorities like the FDA and EU continuously evaluate the efficacy of prevailing devices. To curb the high intravenous infusion pump market demand, prominent healthcare companies keep on bringing updated versions of devices.
Recently, FDA approved the redistribution of BD’s Alaris infusion pump in the market. This latest version is enabled with new software, hardware, and cybersecurity updates to deliver precise medications to the patients.
In August 2023, ICU Medical received 510(k) FDA clearance to its Plum Duo infusion pump, enabled with LifeShield infusion safety software. This pump features a large touch screen that enables an intuitive user interface as well. Similarly, Baxter’s Novum IQ syringe infusion pump (SYR) is paired with Dose IQ safety software that provides enhanced safety features, connectivity and a vast portfolio of sets designed to deliver optimum dose precision.
With a surge in innovations and digital integration into healthcare and medical devices, IOT (internet of things) controlled devices are set to emerge in the market. Researchers are working on developing remote monitoring enabled infusion pumps for accurate detection of patient’s vitals. Such technologies will enhance the intravenous infusion pump market growth in the upcoming years.
Global Intravenous Infusion Pump Market Segmentation
Intravenous Infusion Pump Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Volumetric Infusion Pumps
- Syringe Infusion Pumps
- Patient Controlled Analgesia Infusion Pumps
- Oncology
- Parenteral Nutrition
- Analgesia/Pain Management
- Others
- Hospital and Clinics
- Home Healthcare
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Intravenous Infusion Pump Market Overview
- 3.1 Global Intravenous Infusion Pump Market Historical Value (2018-2024)
- 3.2 Global Intravenous Infusion Pump Market Forecast Value (2025-2034)
- 4 Global Intravenous Infusion Pump Market Landscape
- 4.1 Global Intravenous Infusion Pump: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Intravenous Infusion Pump: Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Applications
- 5 Global Intravenous Infusion Pump Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Intravenous Infusion Pump Market Segmentation
- 6.1 Global Intravenous Infusion Pump Market by Type
- 6.1.1 Market Overview
- 6.1.2 Volumetric Infusion Pumps
- 6.1.3 Syringe Infusion Pumps
- 6.1.4 Patient Controlled Analgesia Infusion Pumps
- 6.2 Global Intravenous Infusion Pump Market by Applications
- 6.2.1 Market Overview
- 6.2.2 Oncology
- 6.2.3 Parenteral Nutrition
- 6.2.4 Analgesia/Pain Management
- 6.2.5 Others
- 6.3 Global Intravenous Infusion Pump Market by End User
- 6.3.1 Market Overview
- 6.3.2 Hospital and Clinics
- 6.3.3 Home Healthcare
- 6.3.4 Others
- 6.4 Global Intravenous Infusion Pump Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Intravenous Infusion Pump Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Intravenous Infusion Pump Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Intravenous Infusion Pump Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Intravenous Infusion Pump Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Intravenous Infusion Pump Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding and Investment Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Supplier Landscape
- 16.1 F. Hoffmann-La Roche Ltd.
- 16.1.1 Financial Analysis
- 16.1.2 Product Portfolio
- 16.1.3 Demographic Reach and Achievements
- 16.1.4 Mergers and Acquisitions
- 16.1.5 Certifications
- 16.2 Fresenius SE & Co. KGaA
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Mergers and Acquisitions
- 16.2.5 Certifications
- 16.3 B. Braun
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Mergers and Acquisitions
- 16.3.5 Certifications
- 16.4 Becton, Dickinson and Company
- 16.4.1 Financial Analysis
- 16.4.2 Product Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Mergers and Acquisitions
- 16.4.5 Certifications
- 16.5 Baxter
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Mergers and Acquisitions
- 16.5.5 Certifications
- 16.6 Terumo Corporation
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Mergers and Acquisitions
- 16.6.5 Certifications
- 16.7 Medtronic Plc
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Mergers and Acquisitions
- 16.7.5 Certifications
- 16.8 Smith Medical
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Mergers and Acquisitions
- 16.8.5 Certifications
- 16.9 ICU Medical
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Mergers and Acquisitions
- 16.9.5 Certifications
- 16.10 Tandem Diabetes Care, Inc
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic Reach and Achievements
- 16.10.4 Mergers and Acquisitions
- 16.10.5 Certifications
- 17 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 18 Company Competitiveness Analysis (Additional Insight)
- 18.1 Very Small Companies
- 18.2 Small Companies
- 18.3 Mid-Sized Companies
- 18.4 Large Companies
- 18.5 Very Large Companies
- 19 Payment Methods (Additional Insight)
- 19.1 Government Funded
- 19.2 Private Insurance
- 19.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.